Page last updated: 2024-09-02

deoxyglucose and Leukemia, Myeloid, Acute

deoxyglucose has been researched along with Leukemia, Myeloid, Acute in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19901 (10.00)18.7374
1990's1 (10.00)18.2507
2000's0 (0.00)29.6817
2010's6 (60.00)24.3611
2020's2 (20.00)2.80

Authors

AuthorsStudies
Bagnoli, JW; Blum, H; Chen-Wichmann, L; Cusan, M; Enard, W; Greif, PA; Hartmann, L; Hiddemann, W; Jeremias, I; Kerbs, P; Krebs, S; Leubolt, G; Redondo Monte, E; Theurich, S; Vick, B; Wichmann, C; Wilding, A1
Aasebø, E; Bartaula-Brevik, S; Bruserud, Ø; Grønningsæter, IS; Hatfield, KJ; Reikvam, H; Tvedt, TH1
Chen, JJ; Fang, ZG; Lin, DJ; Liu, LL; Liu, Q; Long, ZJ; Wang, LX; Wang, SW; Xu, DF; Yan, M; Zheng, FM1
Aller, P; Boyano-Adánez, Mdel C; Calviño, E; Calvo, S; de Blas, E; Estañ, MC; Guillén-Guío, B; Rial, E1
Delabesse, E; Hospital, MA; Larrue, C; Manenti, S; Mansat-De Mas, V; Récher, C; Saland, E; Sarry, JE; Serhan, N; Tamburini, J; Vergez, F1
Garcia-Manero, G; Hu, Y; Huang, A; Huang, P; Ju, HQ; Liu, D; Liu, K; Wen, S; Zhan, G1
Adane, B; Ashton, JM; Crooks, PA; D'Alessandro, A; De, S; Gutman, JA; Hagen, FK; Hansen, KC; Jordan, CT; Khan, N; Minhajuddin, M; Nemkov, T; Pei, S; Pollyea, DA; Smith, C; Stevens, BM; Yadav, VK1
Chen, Y; Hong, M; Huang, J; Li, J; Li, Y; Lian, Y; Mao, J; Qian, S; Wang, S; Xie, Y; Zhao, H; Zhu, Y1
Liu, CK; Qian, GX; Rosen, A; Schmied, R; Schreiber, C; Waxman, S1
Bailly, JD; Bousquet, C; Demur, C; Herbert, JM; Laurent, G; Lautier, D1

Other Studies

10 other study(ies) available for deoxyglucose and Leukemia, Myeloid, Acute

ArticleYear
ZBTB7A prevents RUNX1-RUNX1T1-dependent clonal expansion of human hematopoietic stem and progenitor cells.
    Oncogene, 2020, Volume: 39, Issue:15

    Topics: Animals; Bone Marrow; Carcinogenesis; Cell Cycle Checkpoints; Cell Differentiation; Cell Line, Tumor; Cell Lineage; Core Binding Factor Alpha 2 Subunit; Deoxyglucose; DNA-Binding Proteins; Gene Knockout Techniques; Glycolysis; Hematopoiesis; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid, Acute; Loss of Function Mutation; Mice; Myeloid Progenitor Cells; Oncogene Proteins, Fusion; RUNX1 Translocation Partner 1 Protein; Tetradecanoylphorbol Acetate; Transcription Factors; Xenograft Model Antitumor Assays

2020
Targeting Cellular Metabolism in Acute Myeloid Leukemia and The Role of Patient Heterogeneity.
    Cells, 2020, 05-07, Volume: 9, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Apoptosis; Bridged Bicyclo Compounds, Heterocyclic; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cluster Analysis; Cytarabine; Deoxyglucose; Female; fms-Like Tyrosine Kinase 3; Gene Expression Regulation, Leukemic; Genetic Heterogeneity; Humans; Karyotype; Leukemia, Myeloid, Acute; Male; Mesenchymal Stem Cells; Middle Aged; Mutation; Nuclear Proteins; Nucleophosmin; Proteomics; Sulfonamides; Survival Analysis; Young Adult

2020
Inhibition of mTOR pathway sensitizes acute myeloid leukemia cells to aurora inhibitors by suppression of glycolytic metabolism.
    Molecular cancer research : MCR, 2013, Volume: 11, Issue:11

    Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents; Aurora Kinases; Benzamides; Cell Line, Tumor; Deoxyglucose; Gene Expression Regulation, Neoplastic; Glucose; Glycolysis; HL-60 Cells; Humans; Indoles; Lactic Acid; Leukemia, Myeloid, Acute; Piperazines; Polyploidy; Purines; Quinazolines; Sequestosome-1 Protein; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases; U937 Cells

2013
Apoptotic efficacy of etomoxir in human acute myeloid leukemia cells. Cooperation with arsenic trioxide and glycolytic inhibitors, and regulation by oxidative stress and protein kinase activities.
    PloS one, 2014, Volume: 9, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Deoxyglucose; Epoxy Compounds; Glycolysis; Humans; Indazoles; Leukemia, Myeloid, Acute; Oxidative Stress; Oxides; Protein Kinases

2014
Antileukemic Activity of 2-Deoxy-d-Glucose through Inhibition of N-Linked Glycosylation in Acute Myeloid Leukemia with FLT3-ITD or c-KIT Mutations.
    Molecular cancer therapeutics, 2015, Volume: 14, Issue:10

    Topics: Animals; Antineoplastic Agents; Apoptosis; Benzothiazoles; Biphenyl Compounds; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cytarabine; Deoxyglucose; Drug Resistance, Neoplasm; fms-Like Tyrosine Kinase 3; Glycolysis; Glycosylation; Humans; Leukemia, Myeloid, Acute; Mice, Inbred NOD; Mice, SCID; Mutation; Myeloid Cell Leukemia Sequence 1 Protein; Nitrophenols; Phenylurea Compounds; Piperazines; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-kit; Signal Transduction; Sulfonamides; Xenograft Model Antitumor Assays

2015
Metabolic alterations and drug sensitivity of tyrosine kinase inhibitor resistant leukemia cells with a FLT3/ITD mutation.
    Cancer letters, 2016, 07-28, Volume: 377, Issue:2

    Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Deoxyglucose; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; fms-Like Tyrosine Kinase 3; G2 Phase Cell Cycle Checkpoints; Genetic Predisposition to Disease; Glycolysis; Humans; Leukemia, Myeloid, Acute; Mice; Mitochondria; Mutation; Niacinamide; Phenotype; Phenylurea Compounds; Protein Kinase Inhibitors; Pyruvates; Signal Transduction; Sorafenib; Tandem Repeat Sequences; Time Factors

2016
Rational Design of a Parthenolide-based Drug Regimen That Selectively Eradicates Acute Myelogenous Leukemia Stem Cells.
    The Journal of biological chemistry, 2016, Oct-14, Volume: 291, Issue:42

    Topics: Antineoplastic Combined Chemotherapy Protocols; Deoxyglucose; Female; Gene Expression Regulation, Leukemic; Humans; Leukemia, Myeloid, Acute; Male; NADP; Neoplasm Proteins; Neoplastic Stem Cells; NF-E2-Related Factor 2; Sesquiterpenes; Sirolimus; Up-Regulation

2016
TIGAR cooperated with glycolysis to inhibit the apoptosis of leukemia cells and associated with poor prognosis in patients with cytogenetically normal acute myeloid leukemia.
    Journal of hematology & oncology, 2016, 11-25, Volume: 9, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Case-Control Studies; Cell Line, Tumor; Cell Proliferation; Child; Deoxyglucose; Female; Gene Knockdown Techniques; Glycolysis; Heterografts; Humans; Imidazoles; Intracellular Signaling Peptides and Proteins; Leukemia, Myeloid, Acute; Male; Mice; Middle Aged; Phosphofructokinase-2; Phosphoric Monoester Hydrolases; Piperazines; Prognosis; RNA, Small Interfering; Tumor Cells, Cultured; Young Adult

2016
Glycosyltransferase alterations are cell type related when human promyelocytic leukemia (HL-60) cells are treated with various inducers of differentiation.
    Experimental hematology, 1983, Volume: 11, Issue:8

    Topics: Cell Line; Cell Transformation, Neoplastic; Decarboxylation; Deoxyglucose; Dimethyl Sulfoxide; Fucosyltransferases; Galactosyltransferases; Hexosyltransferases; Humans; Leukemia, Myeloid, Acute; Sialyltransferases; Substrate Specificity; Tetradecanoylphorbol Acetate; Tretinoin

1983
Altered intracellular distribution of daunorubicin in immature acute myeloid leukemia cells.
    International journal of cancer, 1997, Apr-10, Volume: 71, Issue:2

    Topics: Antibiotics, Antineoplastic; Antigens, CD34; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azides; Blood Cells; Cell Nucleus; Colchicine; Cytochalasin B; Cytoplasm; Daunorubicin; Deoxyglucose; Fluorescent Antibody Technique, Indirect; Humans; Leukemia, Myeloid, Acute; Microscopy, Confocal; Monensin; Nigericin; Sodium Azide; Temperature; Tumor Cells, Cultured

1997